US · Healthcare

China Medicine Corporation (CHME)

Medical Distribution

China Medicine Corporation (CHME) is listed on US in the Healthcare sector. Industry: Medical Distribution. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CHME

P/E ratio

18.00

China Medicine Corporation (CHME) — FAQ

What is CHME's P/E ratio?

The price-to-earnings (P/E) ratio for China Medicine Corporation (CHME) is 18.00 (data as of 2026-03-23).

Does China Medicine Corporation pay a dividend?

Dividend yield is not available in the current snapshot for China Medicine Corporation (CHME). Check the MyAverix Finance app for the latest dividend data.

What sector is China Medicine Corporation in?

China Medicine Corporation (CHME) is classified in the Healthcare sector (Medical Distribution industry).

What exchange is CHME listed on?

CHME is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)